Monaco

Monaco

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.67 (0.54 - 0.78) 2019 Modelled IHME
0.7 (0.58 - 0.82) 2018 Modelled IHME
0.72 (0.59 - 0.85) 2017 Modelled IHME
0.72 (0.59 - 0.85) 2016 Modelled IHME
0.72 (0.59 - 0.86) 2015 Modelled IHME
0.73 (0.59 - 0.85) 2014 Modelled IHME
0.74 (0.60 - 0.86) 2013 Modelled IHME
0.75 (0.61 - 0.87) 2012 Modelled IHME
0.76 (0.62 - 0.88) 2011 Modelled IHME
0.77 (0.63 - 0.90) 2010 Modelled IHME
0.77 (0.63 - 0.91) 2009 Modelled IHME
0.78 (0.64 - 0.92) 2008 Modelled IHME
0.79 (0.64 - 0.93) 2007 Modelled IHME
0.8 (0.64 - 0.95) 2006 Modelled IHME
0.81 (0.64 - 0.96) 2005 Modelled IHME
0.82 (0.65 - 0.97) 2004 Modelled IHME
0.83 (0.67 - 0.97) 2003 Modelled IHME
0.84 (0.69 - 0.98) 2002 Modelled IHME
0.85 (0.70 - 0.99) 2001 Modelled IHME
0.85 (0.70 - 1.01) 2000 Modelled IHME
0.86 (0.70 - 1.01) 1999 Modelled IHME
0.87 (0.71 - 1.02) 1998 Modelled IHME
0.87 (0.70 - 1.04) 1997 Modelled IHME
0.88 (0.71 - 1.04) 1996 Modelled IHME
0.89 (0.71 - 1.06) 1995 Modelled IHME
0.89 (0.71 - 1.06) 1994 Modelled IHME
0.9 (0.72 - 1.06) 1993 Modelled IHME
0.9 (0.73 - 1.07) 1992 Modelled IHME
0.91 (0.74 - 1.08) 1991 Modelled IHME
0.91 (0.75 - 1.08) 1990 Modelled IHME
0.55 (0.04 - 7.57) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.02 (0.01 - 0.02) 2019 Modelled IHME
0.02 (0.01 - 0.02) 2018 Modelled IHME
0.02 (0.01 - 0.02) 2017 Modelled IHME
0.02 (0.01 - 0.02) 2016 Modelled IHME
0.02 (0.01 - 0.02) 2015 Modelled IHME
0.02 (0.01 - 0.02) 2014 Modelled IHME
0.02 (0.01 - 0.02) 2013 Modelled IHME
0.02 (0.01 - 0.02) 2012 Modelled IHME
0.02 (0.01 - 0.02) 2011 Modelled IHME
0.02 (0.01 - 0.03) 2010 Modelled IHME
0.02 (0.01 - 0.03) 2009 Modelled IHME
0.02 (0.01 - 0.03) 2008 Modelled IHME
0.02 (0.01 - 0.03) 2007 Modelled IHME
0.02 (0.01 - 0.03) 2006 Modelled IHME
0.02 (0.01 - 0.03) 2005 Modelled IHME
0.02 (0.01 - 0.03) 2004 Modelled IHME
0.02 (0.01 - 0.03) 2003 Modelled IHME
0.02 (0.01 - 0.03) 2002 Modelled IHME
0.02 (0.01 - 0.03) 2001 Modelled IHME
0.02 (0.01 - 0.03) 2000 Modelled IHME
0.02 (0.01 - 0.03) 1999 Modelled IHME
0.02 (0.01 - 0.03) 1998 Modelled IHME
0.02 (0.01 - 0.03) 1997 Modelled IHME
0.02 (0.01 - 0.03) 1996 Modelled IHME
0.02 (0.01 - 0.03) 1995 Modelled IHME
0.04 (0.03 - 0.05) 1994 Modelled IHME
0.09 (0.06 - 0.13) 1993 Modelled IHME
0.17 (0.11 - 0.24) 1992 Modelled IHME
0.26 (0.17 - 0.37) 1991 Modelled IHME
0.37 (0.23 - 0.52) 1990 Modelled IHME
0.2 (0.01 - 2.94) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.44 (2.41 - 4.68) 2019 Modelled IHME
3.45 (2.42 - 4.71) 2018 Modelled IHME
3.47 (2.46 - 4.69) 2017 Modelled IHME
3.48 (2.47 - 4.72) 2016 Modelled IHME
3.5 (2.48 - 4.76) 2015 Modelled IHME
3.52 (2.52 - 4.77) 2014 Modelled IHME
3.54 (2.53 - 4.78) 2013 Modelled IHME
3.53 (2.53 - 4.77) 2012 Modelled IHME
3.52 (2.52 - 4.75) 2011 Modelled IHME
3.53 (2.49 - 4.80) 2010 Modelled IHME
3.52 (2.45 - 4.71) 2009 Modelled IHME
3.51 (2.41 - 4.71) 2008 Modelled IHME
3.51 (2.41 - 4.77) 2007 Modelled IHME
3.51 (2.40 - 4.79) 2006 Modelled IHME
3.49 (2.36 - 4.80) 2005 Modelled IHME
3.61 (2.43 - 4.93) 2004 Modelled IHME
3.91 (2.66 - 5.34) 2003 Modelled IHME
4.22 (2.91 - 5.70) 2002 Modelled IHME
4.41 (3.08 - 5.98) 2001 Modelled IHME
4.34 (3.01 - 5.88) 2000 Modelled IHME
4.03 (2.79 - 5.47) 1999 Modelled IHME
3.76 (2.61 - 5.16) 1998 Modelled IHME
3.56 (2.46 - 4.87) 1997 Modelled IHME
3.43 (2.38 - 4.68) 1996 Modelled IHME
3.34 (2.33 - 4.58) 1995 Modelled IHME
3.29 (2.31 - 4.53) 1994 Modelled IHME
3.3 (2.30 - 4.58) 1993 Modelled IHME
3.28 (2.28 - 4.54) 1992 Modelled IHME
3.26 (2.30 - 4.46) 1991 Modelled IHME
3.25 (2.29 - 4.43) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1 (1 - 2) 2019 Modelled IHME
1 (1 - 2) 2018 Modelled IHME
1 (1 - 2) 2017 Modelled IHME
1 (1 - 2) 2016 Modelled IHME
1 (1 - 2) 2015 Modelled IHME
1 (1 - 2) 2014 Modelled IHME
1 (1 - 2) 2013 Modelled IHME
1 (1 - 2) 2012 Modelled IHME
1 (1 - 2) 2011 Modelled IHME
1 (1 - 2) 2010 Modelled IHME
1 (1 - 2) 2009 Modelled IHME
1 (1 - 2) 2008 Modelled IHME
1 (1 - 2) 2007 Modelled IHME
1 (1 - 2) 2006 Modelled IHME
1 (1 - 2) 2005 Modelled IHME
1 (1 - 2) 2004 Modelled IHME
1 (1 - 2) 2003 Modelled IHME
1 (1 - 2) 2002 Modelled IHME
1 (1 - 2) 2001 Modelled IHME
1 (1 - 2) 2000 Modelled IHME
1 (1 - 2) 1999 Modelled IHME
1 (1 - 2) 1998 Modelled IHME
1 (1 - 2) 1997 Modelled IHME
1 (1 - 2) 1996 Modelled IHME
1 (1 - 1) 1995 Modelled IHME
1 (1 - 1) 1994 Modelled IHME
1 (1 - 1) 1993 Modelled IHME
1 (1 - 1) 1992 Modelled IHME
1 (1 - 1) 1991 Modelled IHME
1 (1 - 1) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
11 (8 - 17) 2019 Modelled IHME
11 (8 - 17) 2018 Modelled IHME
11 (8 - 17) 2017 Modelled IHME
11 (8 - 17) 2016 Modelled IHME
11 (8 - 17) 2015 Modelled IHME
11 (8 - 17) 2014 Modelled IHME
11 (8 - 17) 2013 Modelled IHME
11 (8 - 17) 2012 Modelled IHME
11 (8 - 17) 2011 Modelled IHME
11 (8 - 17) 2010 Modelled IHME
11 (8 - 17) 2009 Modelled IHME
11 (8 - 17) 2008 Modelled IHME
11 (8 - 17) 2007 Modelled IHME
11 (8 - 17) 2006 Modelled IHME
11 (8 - 17) 2005 Modelled IHME
12 (8 - 17) 2004 Modelled IHME
12 (8 - 17) 2003 Modelled IHME
12 (8 - 18) 2002 Modelled IHME
12 (8 - 19) 2001 Modelled IHME
13 (9 - 19) 2000 Modelled IHME
13 (9 - 19) 1999 Modelled IHME
13 (9 - 19) 1998 Modelled IHME
13 (9 - 19) 1997 Modelled IHME
13 (9 - 19) 1996 Modelled IHME
13 (9 - 19) 1995 Modelled IHME
13 (9 - 19) 1994 Modelled IHME
13 (9 - 19) 1993 Modelled IHME
13 (9 - 19) 1992 Modelled IHME
13 (9 - 19) 1991 Modelled IHME
13 (9 - 19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
99 1999 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.11 (0.90 - 1.36) 2019 Modelled IHME
1.11 (0.90 - 1.37) 2018 Modelled IHME
1.1 (0.90 - 1.37) 2017 Modelled IHME
1.09 (0.89 - 1.35) 2016 Modelled IHME
1.08 (0.89 - 1.33) 2015 Modelled IHME
1.08 (0.89 - 1.33) 2014 Modelled IHME
1.09 (0.89 - 1.33) 2013 Modelled IHME
1.09 (0.89 - 1.34) 2012 Modelled IHME
1.09 (0.89 - 1.34) 2011 Modelled IHME
1.09 (0.89 - 1.33) 2010 Modelled IHME
1.09 (0.89 - 1.33) 2009 Modelled IHME
1.08 (0.89 - 1.33) 2008 Modelled IHME
1.08 (0.88 - 1.32) 2007 Modelled IHME
1.07 (0.87 - 1.32) 2006 Modelled IHME
1.06 (0.86 - 1.31) 2005 Modelled IHME
1.05 (0.86 - 1.29) 2004 Modelled IHME
1.04 (0.85 - 1.28) 2003 Modelled IHME
1.03 (0.84 - 1.26) 2002 Modelled IHME
1.02 (0.84 - 1.26) 2001 Modelled IHME
1.01 (0.83 - 1.23) 2000 Modelled IHME
1 (0.82 - 1.22) 1999 Modelled IHME
0.98 (0.80 - 1.20) 1998 Modelled IHME
0.97 (0.79 - 1.19) 1997 Modelled IHME
0.95 (0.78 - 1.18) 1996 Modelled IHME
0.94 (0.77 - 1.16) 1995 Modelled IHME
0.93 (0.77 - 1.15) 1994 Modelled IHME
0.93 (0.76 - 1.14) 1993 Modelled IHME
0.92 (0.75 - 1.13) 1992 Modelled IHME
0.91 (0.74 - 1.12) 1991 Modelled IHME
0.91 (0.74 - 1.11) 1990 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.4 (8.61 - 14.80) 2019 Modelled IHME
11.5 (8.67 - 14.80) 2018 Modelled IHME
11.6 (8.70 - 14.80) 2017 Modelled IHME
11.6 (8.87 - 14.70) 2016 Modelled IHME
11.7 (8.97 - 14.80) 2015 Modelled IHME
11.8 (9.09 - 14.80) 2014 Modelled IHME
11.8 (9.12 - 14.90) 2013 Modelled IHME
11.8 (9.05 - 14.90) 2012 Modelled IHME
11.8 (8.93 - 14.90) 2011 Modelled IHME
11.8 (8.92 - 14.80) 2010 Modelled IHME
11.8 (8.81 - 14.80) 2009 Modelled IHME
11.8 (8.66 - 14.80) 2008 Modelled IHME
11.8 (8.58 - 14.90) 2007 Modelled IHME
11.8 (8.60 - 15) 2006 Modelled IHME
11.7 (8.56 - 14.90) 2005 Modelled IHME
11.6 (8.30 - 14.80) 2004 Modelled IHME
11.4 (8.06 - 14.90) 2003 Modelled IHME
11.1 (7.75 - 14.50) 2002 Modelled IHME
10.6 (7.48 - 13.80) 2001 Modelled IHME
9.81 (6.98 - 12.90) 2000 Modelled IHME
8.76 (6.11 - 11.50) 1999 Modelled IHME
7.92 (5.52 - 10.50) 1998 Modelled IHME
7.31 (5.18 - 9.66) 1997 Modelled IHME
6.91 (4.93 - 9.10) 1996 Modelled IHME
6.67 (4.71 - 8.73) 1995 Modelled IHME
6.52 (4.64 - 8.55) 1994 Modelled IHME
6.55 (4.68 - 8.63) 1993 Modelled IHME
6.48 (4.59 - 8.46) 1992 Modelled IHME
6.44 (4.62 - 8.45) 1991 Modelled IHME
6.4 (4.61 - 8.42) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4 (3 - 6) 2019 Modelled IHME
4 (3 - 6) 2018 Modelled IHME
4 (3 - 6) 2017 Modelled IHME
4 (3 - 5) 2016 Modelled IHME
4 (3 - 5) 2015 Modelled IHME
4 (3 - 5) 2014 Modelled IHME
4 (3 - 5) 2013 Modelled IHME
4 (3 - 5) 2012 Modelled IHME
4 (3 - 5) 2011 Modelled IHME
4 (3 - 5) 2010 Modelled IHME
4 (3 - 5) 2009 Modelled IHME
4 (3 - 5) 2008 Modelled IHME
4 (3 - 5) 2007 Modelled IHME
4 (3 - 5) 2006 Modelled IHME
4 (3 - 5) 2005 Modelled IHME
4 (3 - 5) 2004 Modelled IHME
4 (3 - 5) 2003 Modelled IHME
4 (3 - 5) 2002 Modelled IHME
4 (2 - 5) 2001 Modelled IHME
3 (2 - 4) 2000 Modelled IHME
3 (2 - 4) 1999 Modelled IHME
3 (2 - 3) 1998 Modelled IHME
2 (2 - 3) 1997 Modelled IHME
2 (2 - 3) 1996 Modelled IHME
2 (2 - 3) 1995 Modelled IHME
2 (1 - 3) 1994 Modelled IHME
2 (1 - 3) 1993 Modelled IHME
2 (1 - 3) 1992 Modelled IHME
2 (1 - 3) 1991 Modelled IHME
2 (1 - 3) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
41 (31 - 52) 2019 Modelled IHME
41 (32 - 52) 2018 Modelled IHME
41 (32 - 51) 2017 Modelled IHME
41 (31 - 52) 2016 Modelled IHME
41 (31 - 51) 2015 Modelled IHME
41 (31 - 51) 2014 Modelled IHME
41 (31 - 51) 2013 Modelled IHME
42 (31 - 51) 2012 Modelled IHME
42 (31 - 51) 2011 Modelled IHME
42 (32 - 52) 2010 Modelled IHME
42 (32 - 52) 2009 Modelled IHME
42 (32 - 52) 2008 Modelled IHME
42 (32 - 52) 2007 Modelled IHME
42 (32 - 52) 2006 Modelled IHME
42 (32 - 52) 2005 Modelled IHME
42 (31 - 52) 2004 Modelled IHME
42 (31 - 52) 2003 Modelled IHME
42 (31 - 52) 2002 Modelled IHME
41 (31 - 52) 2001 Modelled IHME
41 (30 - 52) 2000 Modelled IHME
41 (30 - 51) 1999 Modelled IHME
41 (30 - 51) 1998 Modelled IHME
41 (30 - 51) 1997 Modelled IHME
41 (30 - 51) 1996 Modelled IHME
41 (31 - 51) 1995 Modelled IHME
41 (30 - 51) 1994 Modelled IHME
41 (30 - 51) 1993 Modelled IHME
41 (30 - 51) 1992 Modelled IHME
41 (30 - 51) 1991 Modelled IHME
41 (30 - 51) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.67 (%)
2019
(0.54 - 0.78(%))
IHME
HCV (RNA/cAg+)
1.11 (%)
2019
(0.9 - 1.36(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
1
2019
(1 - 2)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4
2019
(3 - 6)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.02 (%)
2019, latest modelled
(0.01 - 0.02(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources